The global Separation Systems for Commercial Biotechnology market size is predictable at 40.95 billion USD with a CAGR of 7.4% during the forecasted period from 2021-2028.
The global Separation Systems for Commercial Biotechnology market size is predictable at 40.95 billion USD with a CAGR of 7.4% during the forecasted period from 2021-2028. The key factors driving the growth of Separation Systems for Commercial Biotechnology market is attributed to rising need of novel drug molecules and expanding biotech & pharma companies across the globe. Also, soaring chronic diseases, genetic disorders, etc. are eventually raising the demand for therapeutics. In addition, increasing government funding coupled with extensive research & development activities is boosting the demand for this market. Moreover, high-tech innovations and mergers between prominent players for product development is projected to show lucrative growth opportunities in this market. On the other hand, high cost associated with these separation systems is expected to limit the growth of this market.
Table of Content 1. Market Introduction 1.1. Executive Summary 1.2. Market Definition 1.3. Market Scope 2. Research Methodology 2.1. Primary Research 2.2. Research Methodology 2.3. Assumptions & Exclusions 2.4. Secondary data sources 3. Separation Systems For Commercial Biotechnology Market Overview 3.1. Report Segmentation & Scope 3.2. Key Market Trend 3.3. Drivers 3.3.1. Increasing demand for novel drug molecules and cell-based therapies 3.3.2. Commercial separation systems in the biotechnology industry 3.3.3. Growing demand for microarray technology 3.4. Restraints 3.4.1. Lack of improvisation in electrophoresis equipment technology 3.4.2. High cost of technologies & systems 3.5. Opportunities 3.5.1. Investment in research & development of the technology 3.5.2. Increased participation of government agencies, rising number of biotech firms 3.6. Porter’s Five Forces Analysis 3.6.1. Porter’s Five Forces Analysis 3.7. Market Share Analysis 4. Product Type Overview 4.1. Introduction 4.1.1. Market Size & Forecast 4.2. Membrane Filters 4.2.1. Market Size & Forecast 4.3. Flow Cytometer 4.3.1. Market Size & Forecast 4.4. DNA Microarray 4.4.1. Market Size & Forecast 4.5. Protein Microarray 4.5.1. Market Size & Forecast 4.6. MACS & FACS Systems 4.6.1. Market Size & Forecast 4.7. Centrifugation Systems 4.7.1. Market Size & Forecast 4.8. Liquid Chromatography 4.8.1. Market Size & Forecast 4.9. Electrophoresis Units 4.9.1. Market Size & Forecast 4.10. Others (biochips, lab-on-a-chip, etc.) 4.10.1. Market Size & Forecast 4.11. undefined 4.11.1. Market Size & Forecast 5. End User Overview 5.1. Introduction 5.1.1. Market Size & Forecast 5.2. Food & Cosmetics 5.2.1. Market Size & Forecast 5.3. Agriculture 5.3.1. Market Size & Forecast 5.4. Energy 5.4.1. Market Size & Forecast 5.5. Life Sciences Research 5.5.1. Market Size & Forecast 5.6. Pharmaceuticals 5.6.1. Market Size & Forecast 6. Separation Systems For Commercial Biotechnology Market Regional Overview 6.1. Introduction 6.1.1. Market Size & Forecast 6.2. North America Separation Systems For Commercial Biotechnology Market 6.2.1. North America Market Size & Forecast, By Country 6.2.2. North America Market Size & Forecast, By Product Type 6.2.3. North America Market Size & Forecast, By End User 6.2.4. U.S. 6.2.4.1. Market Size and Forecast 6.2.5. Canada 6.2.5.1. Market Size and Forecast 6.2.6. Mexico 6.2.6.1. Market Size and Forecast 6.3. Europe Separation Systems For Commercial Biotechnology Market 6.3.1. Europe Market Size & Forecast, By Country 6.3.2. Europe Market Size & Forecast, By Product Type 6.3.3. Europe Market Size & Forecast, By End User 6.3.4. Germany 6.3.4.1. Market Size and Forecast 6.3.5. France 6.3.5.1. Market Size and Forecast 6.3.6. UK 6.3.6.1. Market Size and Forecast 6.3.7. Italy 6.3.7.1. Market Size and Forecast 6.3.8. Spain 6.3.8.1. Market Size and Forecast 6.3.9. Rest of Europe 6.3.9.1. Market Size and Forecast 6.4. Asia-Pacific Separation Systems For Commercial Biotechnology Market 6.4.1. Asia-Pacific Market Size & Forecast, By Country 6.4.2. Asia-Pacific Market Size & Forecast, By Product Type 6.4.3. Asia-Pacific Market Size & Forecast, By End User 6.4.4. Japan 6.4.4.1. Market Size and Forecast 6.4.5. China 6.4.5.1. Market Size and Forecast 6.4.6. Australia 6.4.6.1. Market Size and Forecast 6.4.7. India 6.4.7.1. Market Size and Forecast 6.4.8. South Korea 6.4.8.1. Market Size and Forecast 6.4.9. Rest of Asia-Pacific 6.4.9.1. Market Size and Forecast 6.5. South America Separation Systems For Commercial Biotechnology Market 6.5.1. South America Market Size & Forecast, By Country 6.5.2. South America Market Size & Forecast, By Product Type 6.5.3. South America Market Size & Forecast, By End User 6.5.4. Brazil 6.5.4.1. Market Size and Forecast 6.5.5. Argentina 6.5.5.1. Market Size and Forecast 6.5.6. Rest of South America 6.5.6.1. Market Size and Forecast 6.6. Middle East & Africa Separation Systems For Commercial Biotechnology Market 6.6.1. Middle East & Africa Market Size & Forecast, By Country 6.6.2. Middle East & Africa Market Size & Forecast, By Product Type 6.6.3. Middle East & Africa Market Size & Forecast, By End User 6.6.4. GCC Countries 6.6.4.1. Market Size and Forecast 6.6.5. Egypt 6.6.5.1. Market Size and Forecast 6.6.6. South Africa 6.6.6.1. Market Size and Forecast 6.6.7. Rest of Middle East & Africa 6.6.7.1. Market Size and Forecast 7. Company Profile 7.1. Agilent Technologies 7.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.1.2. Agilent Technologies Product Category, Application, and Specification 7.1.3. Agilent Technologies Financial Performance (2016-2018) 7.1.4. Main Business/Business Overview 7.2. Becton, Dickinson and Company 7.3. BioMérieux SA 7.4. Bio-Rad Laboratories, Inc. 7.5. Danaher 7.6. GE Healthcare 7.7. Hitachi Koki Co., Ltd. 7.8. Merck & Co., Inc. 7.9. Miltenyi Biotec 7.10. PerkinElmer, Inc. 7.11. QIAGEN 7.12. Sartorius 7.13. Shimadzu Corporation 7.14. Thermo Fisher Scientific 7.15. Waters Corporation
(US)
